Over the course of the past week or so, the Auris Medical Holding Ltd (NASDAQ: EARS) stock has emerged as one of the major gainers and the rally continued on Tuesday.
Yesterday, the stock soared by as high as 52% and took the total gains for the past week to 85%. While the gains made by the Auris stock are eye-catching, it is also necessary to point out that there has been no news about the company that could have brought about such gains in recent days.
In such a situation, it might be a good idea to take a closer look at the company and its business. The company is already designated as a clinical-stage operator and is engaged in the development of products for medical needs that remain unmet. The company, which was established in 2003, currently has a range of products in its pipeline and some of the products are meant for vertigo, allergens, and weight gain among others.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.